Lucid Diagnostics
Lucid Diagnostics to Raise $15.3M in Registered Direct Offering
The firm intends to use the net proceeds from the offering for working capital and other general corporate purposes.
Researchers Receive $8M NIH Grant to Evaluate Lucid Diagnostics Esophageal Precancer Test
The researchers will conduct a five-year study to evaluate the firm's collection device and test in patients without symptoms of chronic gastroesophageal reflux disease.
In Brief This Week: T2 Biosystems, Danaher, Agilent, Lucid Diagnostics, More
News items for the week of Feb. 17, 2025.
In Brief This Week: Natera, Becton Dickinson, Tempus, T2 Biosystems, Bio-Rad, More
News items for the week of Dec. 16, 2024.
The company also recently published multiple new clinical validation studies to support its quest for reimbursement.